IXJ Fact Sheet: iShares Global Healthcare ETF
Share
$110.70
close, Nov 18, 2026
Over the year to Nov 18, 2026, IXJ returned +17.2% in total and charged 0.38% a year.
- 1-year total return
- +17.2%
- to Nov 18, 2026
- Expense ratio
- 0.38%
- a year
- Net assets
- $4.6bn
- on Nov 18, 2026
- Net flow, last 5 trading days
- $0
- daily basis to Nov 17, 2026
Growth of $10,000, 1 year
IXJ $11,723 +17.2% · Total return, distributions reinvested, Nov 18, 2025 to Nov 18, 2026.
Returns
WindowTotal return
1 month+4.0%
3 months+3.1%
Year to date+14.7%
1 year+17.2%
3 years+40.9%
5 years+36.6%
Total return, distributions reinvested, each window to Nov 18, 2026.
Ten largest positions
HoldingWeight
ELI LILLY & COMPANY11.60%
JOHNSON & JOHNSON6.88%
ABBVIE5.30%
MERCK & CO INC3.98%
UNITEDHEALTH GROUP3.94%
ROCHE PS PAR AG3.83%
NOVARTIS AG3.28%
ASTRAZENECA PLC3.18%
THERMO FISHER SCIENTIFIC2.86%
AMGEN INC2.79%
IXJ top ten by weight, 47.6% of the fund, of its 110 equity positions, from the holdings published by its issuer for Nov 17, 2026.
Facts
Equity fund · Tracks the S&P Global 1200 Health Care Index · First traded Nov 26, 2001 · Benchmark Its own holdings, as of Nov 17, 2026